Skip to main content
Caplight Logo









Sequentify

Sequentify

Private
IsraelHealthcare & Life Scienceshttps://www.sequentify.com/

Last Round

Grant

Jan 11, 2024

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sequentify is a biotechnology company that provides library-preparation solutions and AI software for next-generation sequencing to enable faster and more cost-effective genomic testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

NGSnext-generation sequencinglibrary preparationgenomic sequencinglab reagentsbiotech kitsbioinformatics softwareNGS workflowgenomicsclinical diagnosticssample preparationlife sciences toolsgenomic analysisclinical annotationlab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sequentify Comparables

Compare Sequentify with similar companies based on industry and business-model similarity.

Sequentify comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Micronbrane Medical
79%
SeqWell
79%
Quantabio
76%

Sequentify Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 11, 2024
SeedMay 10, 2022

Key People

Founding team and executive leadership

Tom Fleischer

Co-founder & CEO

Founding Team

Sequentify Investors

Notable investors and investment history

Sequentify investors
InvestorRounds
Israel Innovation AuthorityGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 226% MoM, reaching 2K.

  • Jul 31, 2025

    Appointed Dr. Ravi Majeti, an expert in hematologic malignancies.

Sequentify Filings

Explore SEC and related filing metadata, where available.

Sequentify filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sequentify's valuation, stock price, and market status.

Is Sequentify a public or private company?

Sequentify is a private company.

What is the current stock price of Sequentify?

Sequentify is a private company, so its shares have no public market price. Caplight tracks Sequentify's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sequentify worth (valuation)?

Valuation information for Sequentify is not publicly available.

Can I buy Sequentify stock?

Sequentify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sequentify's last funding round?

Sequentify's most recent funding round was Grant on January 11, 2024.

Who are the main investors in Sequentify?

Key investors in Sequentify include Israel Innovation Authority.

Will Sequentify IPO soon?

No public IPO plans have been announced for Sequentify.

How can I track Sequentify secondary market activity?

Caplight tracks bids, offers, and trades in Sequentify's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range7
Year Founded2021
Last FundingJan 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?